ETF 투자 완벽 가이드: 처음부터 실전까지 4단계로 마스터하기

 

ETF 투자를 막 시작하려는 분들을 위해, 복잡한 용어부터 실제 매수까지 모든 것을 한눈에 정리해 드리는 4단계 입문 시리즈를 준비했습니다. 이 시리즈 하나로 ETF 투자에 대한 모든 궁금증을 해결하고 자신감을 얻어가세요!


1편: ETF란? 주식바구니 이야기로 쉽게!

ETF 투자의 첫걸음을 떼는 여러분을 위해, ETF의 기본 개념을 '주식바구니'라는 비유를 통해 쉽고 재미있게 풀어냈습니다. 복잡하게만 느껴졌던 ETF의 정체를 명쾌하게 파악해보세요.


인덱스의 기본적인 의미부터 인덱스 ETF와의 차이점까지, 핵심 내용을 단계별로 차근차근, 그리고 최대한 자세하게 설명해 드립니다. 인덱스 ETF의 모든 것을 완벽하게 이해할 수 있습니다.


4편: 토스 소수점 투자, 실전 가이드

실제로 토스 앱을 통해 소수점 투자를 어떻게 진행하는지, 수수료는 어떻게 적용되는지, 그리고 환율을 유리하게 활용하는 팁까지 실전적인 내용을 담았습니다. 이제 망설이지 말고 소액으로 투자를 시작해보세요.



Popular posts from this blog

Stock Market Today (09/25/2025): Key Data to Watch After Record Highs

Image
US Stock Market Pullback 2025: A Breather or a Warning Sign? Author: CORNYVERSE Last updated: September 26, 2025 | Reading time: 9 minutes Quick Navigation 1. Market Recap: A Three-Day Cooling Period 2. Key Drivers: Why Did Stocks Drop? 3. Sector Spotlight: Energy Shines, Tech Dives 4. Global Context: How World Markets Reacted 5. What to Watch Next: The Road Ahead After a dizzying climb to record highs, the US stock market is finally taking a much-needed breath. But is this three-day dip just a healthy pause, or the start of something more serious? For beginner and intermediate investors, understanding these shifts is key. Let's break down exactly what happened and what everyone should be watching.   Key Takeaways Three-Day Pullback: Major US indices, including the Dow, S&P 500, and Nasdaq, fell for a third straight session through Thursday, September 25th, after hitting all-time highs on Monday. Fed & GDP Influence: The dip was fueled by Fe...
Read more

Wegovy vs Mounjaro/Zepbound: Mechanism, Korea/U.S. Pricing, and Investor Takeaways at a Glance

Image
At the center of today’s weight-loss and metabolic-disease care are GLP-1 class (and dual-agonist) injectables. Below we distill the essentials comparing Novo Nordisk’s Wegovy (semaglutide) with Eli Lilly’s Mounjaro/Zepbound (tirzepatide) , then add investor angles on both companies and Korea-focused ripple effects across healthcare. Note for international readers: figures and policy/pricing references are Korea-facing and current as of Aug 29, 2025.   🎯 Key Takeaways ✅ Mechanism: Wegovy = single GLP-1; Mounjaro/Zepbound = dual GIP + GLP-1 agonist ✅ Korea pricing (ex-factory): From August, Wegovy moved to dose-tiered pricing (0.25 mg ≈ ₩216,000–₩223,200). Mounjaro: 2.5 mg ₩278,066; 5 mg ₩369,307. ✅ Investing: Lilly and Novo keep expanding capacity and growing sales. Risks include rich valuation, competition, and progress on oral programs. • Healthcare spillovers (Korea view): A...
Read more